Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- January 2020
- DOI:
- 10.1371/journal.pone.0227104
- Bibcode:
- 2020PLoSO..1527104G